FOS and bone inflammation disease: Considering the role of the PPAR-γ/cFos (AP-1) pathway in the regulation of the transcription factor NFATc1, a major regulator of osteoclastogenesis, further studies are needed to explore SO in the treatment of inflammatory bone diseases [149].